XGN

Conviction 49HealthcareScan · Thu, Jun 25, 2026

XGN$4.64+2.65%

ResistanceSupportVol 14

Vol MA14 237.08K

Mar 26Apr 14May 1May 19Jun 8Jun 25

EXAGEN INC.SERVICES-MEDICAL LABORATORIESwww.exagen.com ↗

Price4.64

Change+2.65%

Gap+2.99%

Rel volume0.90×

Avg volume318.19K

Avg $ vol1.5M

SMA 204.58

SMA 503.84

SMA 2005.99

Price vs 50+20.76%

Price vs 200-22.51%

MA stackmixed

50/200 cross—

Supertrendup · 4.12

RSI (14)56

MACD hist-0.05

MACD cross—

Stoch %K / %D72 / 50

ADX (14)29

+DI / −DI24 / 14

RSI divergence—

MACD divergence—

ATR %+7.81%

ADR %8.19%

52w high11.96

52w low2.65

From 52w high-61.20%

Above 52w low+75.09%

New 52w highNo

SqueezeOff

Bollinger width26.02%

%B0.55

Donchian pos36.81%

Donchian high5.55

Donchian low4.11

AVWAP (52w high)5.10

vs AVWAP high-9.10%

AVWAP (52w low)3.89

vs AVWAP low+19.32%

OBV trendFlat

Chaikin MF (20)-0.19

Today vs 20d0.90×

Avg vol (14d)237.08K

Avg vol (20d)318.19K

Avg $ vol (20d)1.5M

Market cap112.1M

RS 3m (vs SPY)+52.71%

RS 6m (vs SPY)-37.44%

RS line new highNo

Trend template3/8

Technical rank34.1

1 week+9.18%

1 month+0.43%

3 months+61.11%

6 months-30.02%

1 year-34.28%

YTD-23.18%

P/E-5.62

P/B7.77

P/S1.68

P/FCF-7.86

EPS-0.9300

Div yield—

ROE-138.24%

ROA-38.40%

Debt/Eq1.58

Current3.47

EV/EBITDA-9.48

Gross margin58.28%

Net margin-29.97%

Rev growth19.65%

EPS growth-31.99%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value113.46M

Revenue17.31M

Net income-3.97M

Gross profit10.21M

Free cash flow-14.27M

IndustrySERVICES-MEDICAL LABORATORIES

ExchangeNasdaq

Shares out24.16M

Employees220

ListedThu, Sep 19, 2019

Free float14.69M

Float %64.8%

Short interest864.74K

Days to cover1.8d

Short volume58.1%

Squeeze score33 / 100

Next earningsTue, Aug 4, 2026 (40d)

EPS forecast−$0.18 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank34.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.36

Support3.06

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XGN

All disclosures →

No recent disclosed trades by Congress in XGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XGN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
KAHN SCOTT D Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22
Stokes Frank Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22
McKhann Chas Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22

SEC filings

EDGAR filings in XGN · 1 recent

EDGAR →

8-K8-KTue, Jun 9, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.